A signature of immune function genes associated with recurrence-free survival in breast cancer patients.
about
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyTherapeutic cancer vaccines: past, present, and futureBioinformatics for cancer immunology and immunotherapyThe STING pathway and the T cell-inflamed tumor microenvironmentAn immunologic portrait of cancerPathophysiological role of guanylate-binding proteins in gastrointestinal diseasesHuman melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomesThe stable traits of melanoma genetics: an alternate approach to target discoveryDual roles for immune metagenes in breast cancer prognosis and therapy prediction.Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Distinct signatures of the immune responses in low risk versus high risk neuroblastomaGene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.miR-30e* is an independent subtype-specific prognostic marker in breast cancerMolecular biomarkers screened by next-generation RNA sequencing for non-sentinel lymph node status prediction in breast cancer patients with metastatic sentinel lymph nodesA genetic inference on cancer immune responsivenessGenomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.Signatures of tumor-immune interactions as biomarkers for breast cancer prognosisCooperativity of adaptive and innate immunity: implications for cancer therapy.Profiling the immune stromal interface in breast cancer and its potential for clinical impactMolecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.CD4⁺ follicular helper T cell infiltration predicts breast cancer survivalIRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypesImmunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunityCXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance.Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.Immunotherapy of cancer: reprogramming tumor-immune crosstalk.Immunotherapy strategies in the treatment of breast cancer.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Immune biomarkers: how well do they serve prognosis in human cancers?Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology.Immunotherapy for the treatment of breast cancer.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
P2860
Q26798404-09DD4329-E42E-4350-9346-04D595C047F2Q26863283-C5A1AA70-F773-4E0F-BDCB-9A8DFA149EF8Q26864876-51D7FC11-1A1C-45BF-949B-5F92674C293DQ27008371-4AC80291-FF72-42F9-B888-D1D32B7A95E5Q27028000-A28709F4-E8D1-4A56-8E79-2420E276F902Q28078361-8D02D4A3-04A0-4236-88FC-DE73976A3088Q30274920-8602698B-B03D-4150-AAB5-3BEF4356697CQ30423599-0477E720-0503-4987-9068-7665ED2C06FAQ33750137-AEBE41C9-9A31-4204-92EA-927F3373C423Q33814856-2601D2EA-FA0E-4D7F-93CA-C6C2F514C0F1Q34248355-48B7830D-38DA-4C73-98F2-862DB9F7FF3BQ34558758-F8EF56DC-986B-4436-A364-E4EA966EA8BAQ35009369-585E7F0B-D8CD-4444-9ABD-48AEC99ABD0CQ35274995-9AFE7981-C257-4EF1-BB31-E520356F2825Q35373780-4DA32606-1C29-4BE8-9D65-CEC2065DA77FQ35541507-2C934912-AEA4-4CAF-B058-6F24F00B60A0Q35863168-55517CA5-DD56-47F7-9DF2-E4AD99F8CD57Q36000900-AEE74B7B-342D-47D7-94F6-07A508B2EA87Q36057497-AD7BF5F8-2B0D-4315-92AA-E471EE9327B9Q36072027-5FBB6CDC-A063-43D8-948F-44F41AFC0602Q36253304-424FDD40-C5FB-421C-BDC2-94C0BDB98310Q36429508-9FA198F3-3B32-4710-A182-40D7A00104F3Q36449295-013B771C-26AC-4EC9-8210-F35BE7D28BACQ36960012-FBC9E2A4-2DDF-4386-89B8-558160F83B3AQ36966923-43334CDE-2A69-43C4-B8AB-2C650871259DQ37003368-720514FB-D757-48C6-92EC-A7A4DF4EFD0EQ37059747-ED746EFD-5BD9-4CF9-A842-B6640CBE4E48Q37142367-F62989A2-16A7-4852-AECD-8100887A0AEDQ37279217-FDDA12E9-FEBC-45A9-AD72-0B200976CE02Q37580494-1FD41D62-87BD-4082-90AA-FFD89C7721D1Q37732220-82EFE920-977A-47E8-AEF3-D099AED8E931Q38055479-8B62840F-4BF0-46F6-8991-BCC89AF04E1DQ38072812-943419A6-339B-494B-9C9C-1C557983FD5DQ38201655-35D3A3C0-75FB-4128-8DC7-5FA37D20A704Q38258842-8DAE8A57-23CE-4E47-91FA-E222C0598923Q38262757-C98C9281-4EBB-4C73-A676-B7B7517AC0F2Q38323254-DCB0C095-8368-4AFF-9E89-28DC5CF2024BQ38353772-54B2207C-1F99-4CAA-8F36-11913FE532E1Q38719813-51C64D19-60A7-4504-A47C-0E56D824751CQ38819190-97A6FB5C-51B5-4C8A-BA3F-F188BB854826
P2860
A signature of immune function genes associated with recurrence-free survival in breast cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A signature of immune function ...... val in breast cancer patients.
@ast
A signature of immune function ...... val in breast cancer patients.
@en
type
label
A signature of immune function ...... val in breast cancer patients.
@ast
A signature of immune function ...... val in breast cancer patients.
@en
prefLabel
A signature of immune function ...... val in breast cancer patients.
@ast
A signature of immune function ...... val in breast cancer patients.
@en
P2093
P2860
P1476
A signature of immune function ...... val in breast cancer patients.
@en
P2093
Catherine Dumur
Francesco M Marincola
Harry D Bear
Maciej Kmieciak
Margaret Grimes
Maria Libera Ascierto
Masoud H Manjili
Michael O Idowu
Rose Manjili
P2860
P2888
P304
P356
10.1007/S10549-011-1470-X
P407
P577
2011-04-11T00:00:00Z